Related Experiment Video
Updated: Aug 26, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Drug-induced kidney injury in Chinese critically ill pediatric patients
1Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Insights
Drug-induced acute kidney injury (DIKI) in critically ill children is often linked to specific medications. Furosemide, midazolam, albumin, fentanyl, glycyrrhizin, vancomycin, and milrinone were identified as high-risk drugs.
Area of Science:
- Pediatric Nephrology
- Clinical Pharmacology
- Critical Care Medicine
Background:
- Drug-induced acute kidney injury (DIKI) is a recognized adverse drug reaction, yet its prevalence and specific drug associations in pediatric populations remain under-investigated.
- The Pediatric Intensive Care database (PIC) provides a valuable resource for studying DIKI in critically ill children.
Purpose of the Study:
- To investigate the incidence and identify key drugs associated with DIKI in Chinese pediatric patients admitted to the intensive care unit.
- To assess the relationship between specific drug exposures and the occurrence of DIKI using established causality assessment scales.
Main Methods:
- Patients with acute kidney injury (AKI) were identified using KDIGO criteria from the PIC database.
- The Naranjo scale was employed to assess the causality of DIKI for suspected drugs.
- Propensity score matching (PSM) was utilized to control for confounders including age, gender, hospital stay duration, and primary diagnosis.
- Unconditional logistic regression analysis was performed to determine significant associations between drug exposure and DIKI.
Main Results:
- A total of 81 pediatric patients with DIKI were identified, with 238 drugs administered 1,863 times.
- Seven drugs were significantly associated with DIKI after analysis: furosemide injection (p=0.001), midazolam injection (p=0.001), 20% albumin prepared from human plasma injection (p=0.004), fentanyl citrate injection (p=0.001), compound glycyrrhizin injection (p=0.026), vancomycin hydrochloride for intravenous (p=0.010), and milrinone lactate injection (p=0.009).
Conclusions:
- Critically ill pediatric patients exhibit a higher risk of developing DIKI when exposed to specific medications.
- Furosemide, midazolam, albumin, fentanyl, glycyrrhizin, vancomycin, and milrinone are identified as key drugs requiring careful monitoring for potential nephrotoxicity in this vulnerable population.
Abstract:
Background: Drug-induced acute kidney injury (DIKI) is a common adverse drug reaction event but is less known in pediatric patients. The study explored the DIKI in Chinese pediatric patients using the Pediatric Intensive Care database (PIC). Method: We screened pediatric patients with acute kidney injury (AKI) using the KDIGO criteria from the PIC and then assessed the relationship between their drugs and DIKI using the Naranjo scale. For the fifteen frequently used DIKI-suspected drugs, we divided patients into drug-exposed and non-exposed groups, using the outcome of whether DIKI was presented or not. Propensity score matching (PSM) was used to control for the effects of four confounders, age, gender, length of hospital stay, and major diagnosis. Unconditional logistic regression was used to identify statistically significant differences between the two groups. Results: A total of 238 drugs were used 1,863 times by the 81 patients with DIKI during their hospital stay. After screening the Naranjo scale to identify the top 15 suspected DIKI drugs with a high frequency of use, we found that furosemide injection (p = 0.001), midazolam injection (p = 0.001), 20% albumin prepared from human plasma injection (p = 0.004), fentanyl citrate injection (p = 0.001), compound glycyrrhizin injection (p = 0.026), vancomycin hydrochloride for intravenous (p = 0.010), and milrinone lactate injection (p = 0.009) were associated with DIKI. Conclusion: In critically ill pediatric patients, DIKI is more likely to occur after using furosemide injection, midazolam injection, 20% albumin prepared from human plasma injection, fentanyl citrate injection, compound glycyrrhizin injection, vancomycin hydrochloride for intravenous, milrinone lactate injection.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

